Sanofi India is trading 0.50% upper at Rs 6,035.00 as compared to its last closing price. Sanofi India has been trading in the price range of 6,035.00 & 5,952.95. Sanofi India has given -1.56% in this year & -1.62% in the last 5 days. Sanofi India has TTM P/E ratio 36.50 as compared to the sector P/E of 22.54.There are 2 analysts who have initiated coverage on Sanofi India. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 119.50 Crores in its last quarter.Listed peers of Sanofi India include Natco Pharma (-0.84%), Caplin Point Laboratories (-1.28%), Sanofi India (0.50%).The Mutual Fund holding in Sanofi India was at 11.26% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Sanofi India was at 5.58% in 31 Mar 2025. The FII holding has decreased from the last quarter.
Updated on Jun 24, 2025, 01:08 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Natco Pharma | Bearish | 867.95 | -0.84 | 15,545.84 | 8.31 | 2.06 | 0.69 | 0.06 |
Caplin Point Laboratories | Neutral | 2,022.00 | -1.28 | 15,468.50 | 29.12 | 5.45 | 0.27 | 0.10 |
Sanofi India | Moderately Bearish | 6,035.00 | 0.50 | 13,898.61 | 40.60 | 16.08 | 1.95 | 1.63 |
Alivus Life Sciences | Bearish | 993.00 | -0.71 | 12,112.28 | 25.26 | 4.34 | 2.25 | 1.81 |
Granules India | Bearish | 497.45 | 2.18 | 12,128.86 | 24.72 | 3.18 | 0.31 | 12.67 |
Meeting Date | Purpose |
---|---|
2025-05-14 | Quarterly Results |
2025-02-27 | Audited Results & Final Dividend |
2024-11-07 | Quarterly Results |
2024-07-26 | Quarterly Results |
2024-05-13 | Quarterly Results |
Sanofi India is trading at 6035.00 as on Mon Jun 23 2025 09:55:01. This is 0.50% upper as compared to its previous closing price of 6005.10.
The market capitalization of Sanofi India is 13898.61 Cr as on Mon Jun 23 2025 09:55:01.
The average broker rating on Sanofi India is Strong Buy. The breakup of analyst rating is given below -
The 52 wk high for Sanofi India is 7593.60 whereas the 52 wk low is 4145.90
Sanofi India can be analyzed on the following key metrics -
Sanofi India reported a net profit of 413.30 Cr in 2024.
The Mutual Fund Shareholding was 11.26% at the end of 31 Mar 2025.